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Lillian Barros, c Ricardo C. Calhelha,c Isabel C. F. R. Ferreira, c
Marina Soković a and Jasmina Glamočlija *a
This study was oriented towards the investigation of the biological properties of three wild growing and
edible Macrolepiota species (M. mastoidea, M. rhacodes and Macrolepiota procera) from Serbia. The
results revealed that the mushrooms have a low caloric value; free sugars such as mannitol and trehalose
were identified; oxalic and malic acids were predominant organic acids, while p-hydroxybenzoic and
p-coumaric acids were identified as the main phenolic compounds. Also, they were a rich source of poly-
unsaturated fatty acids, which dominated over monounsaturated and saturated fatty acids. Three isoforms
of tocopherols were identified and quantified: α-, β-, and δ-tocopherol. Regarding biological properties,
all three species exhibited antioxidant potential, antimicrobial potential and cytotoxic activity within the
different tumour cell lines tested. This study indicates that these species are indeed functional foods, due
to the fact that they are edible, consumable and hold different pharmacological activities.
1. Introduction
Since time immemorial, mushrooms have been consumed all
around the world for their health-beneficial effects and for
being tasty. There are over 2000 mushrooms reported to be
edible, including about 700 with some pharmaceutical activi-
ties.1 Edible mushrooms were traditionally harvested in the
wild; nevertheless, collection from wild areas is still important
in some parts of the world.2 It has been well demonstrated
that wild mushrooms are one of the most important functional
foods and good sources of nutraceuticals.3,4
The fungi of the genus Macrolepiota belong to the family
Agaricaceae (Basidiomycota). Besides the pleasant taste,
Macrolepiota species are also known for their nutritional
value.5,6
Numerous pharmacological properties have been attributed
to mushrooms, including antimicrobial, anticancer, anti-
oxidant, antiviral, immunomodulatory, immunosuppressive,
anti-allergic, anti-inflammatory, and anti-cholesterol activities.7–9
Since mushrooms have been used as a food since ancient
times and their biological functions are continuously explored
nowadays, edible species are gaining extreme importance as
functional foods or functional food ingredients. Microbial re-
sistance to antibiotics, oxidative stress and cancer prevention
is gaining more and more importance when linking natural
product ingredients with the prevention of these medical con-
ditions and illnesses. Antibiotic resistance is a natural
phenomenon that predates the modern selective pressure of
clinical antibiotic use. This fact solely implicates the search for
new alternatives to the existing antibiotics.8 The search for
novel sources of antioxidants became of prime importance in
contemporary science since oxidative stress may lead to
various medical conditions targeting primarily nervous and
cardiovascular systems.10 Prevention of cancer, one of the
most devastating diseases of the modern world, became
important on a daily basis, since numerous risk factors could
lead to the development of such a hardly curable state. Thus,
discovering food with functions in cancer prevention is the
main purpose of numerous scientific studies.11
The objectives of the present study were to investigate the
nutritional composition of three Macrolepiota species:
M. mastoidea, M. rhacodes and M. procera growing wild in
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Serbia, as well as to analyze hydrophilic and lypophilic com-
pounds. Furthermore, we aimed to elucidate the biological
properties of Macrolepiota species in order to classify these
species as functional foods. For such purposes, antioxidant,
antimicrobial and anticancer activities of methanolic extracts
were tested.
2. Materials and methods
2.1. Mushroom material
Fresh fruiting bodies of Macrolepiota mastoidea (Fr.) Singer
(Mm-151-2015) and M. rhacodes (Vittad.) Singer (Mr-171-2015)
were collected in autumn 2015, in the village of Babušnica, in
the area of Pirot city, south Serbia. Fruiting bodies of
M. procera (Scop. ex Fr.) Sing. (Mp-171-2012) were collected
from Divčibare mountain, in central Serbia, in October 2012
and authenticated by Dr Jasmina Glamočlija (Institute for
Biological Research, the University of Belgrade, Serbia).
Samples were prepared as previously described.12
2.2. Nutritional value and chemical composition of wild
Macrolepiota species
2.2.1. Macronutrients. The samples were analyzed for
chemical composition (moisture, proteins, fat, carbohydrates
and ash) using the AOAC procedures.13
2.2.2. Hydrophilic compounds
2.2.2.1. Free sugars. Sugars were analyzed by high perform-
ance liquid chromatography (HPLC) using a refraction index
(RI) detector. This assay was conducted according to a pre-
viously described methodology.14 Quantification was carried
out by the internal standard method, and the results are
expressed in mg per g of lyophilized decoctions.
2.2.2.2. Organic acids. Organic acids were determined by
ultra-fast liquid chromatography (UFLC, Shimadzu 20A series)
coupled with a photo diode array (PDA) detector, after dissol-
ving both water and ethanol extracted powders in metapho-
sphoric acid (4%), at a known concentration.15 The organic
acids were quantified by the comparison of the area of their
peaks recorded at 215 nm with calibration curves obtained
from commercial standards of each compound. The results
were expressed in mg per g of the extract.
2.2.2.3. Phenolic compounds. The analysis was performed
by the same UFLC equipment described for organic acids,
according to a previously described procedure.16 Detection was
carried out with a photodiode array (PDA) detector, using
280 nm as the preferred wavelength. The phenolic acids and
related compounds were quantified by comparison of the area
of their peaks with calibration curves obtained from commer-
cial standards of each compound. The results were expressed
in mg per g of the extract.
2.2.3. Lipophilic compounds
2.3.3.1. Fatty acids. Fatty acids were determined by gas–
liquid chromatography with a flame ionization detection
(GC-FID)/capillary column as described previously.17 Split
injection (1 : 40) was carried out at 250 °C. Fatty acid identifi-
cation was made by comparing the relative retention times of
FAME peaks from samples with standards. The results were
recorded and processed using the Clarity Data Apex 4.0
Software and expressed in the relative percentage of each fatty
acid.
2.2.3.2. Tocopherols. The analysis was carried out using the
HPLC equipment described above coupled to a fluorescence
detector (FP-2020; Jasco) programmed for excitation at 290 nm
and emission at 330 nm according to a previously described
methodology.18 The compounds were identified by chromato-
graphic comparisons with authentic standards. Quantification
was based on the fluorescence signal response of each stan-
dard, using the IS (tocol) method and by using calibration
curves obtained from commercial standards of each com-
pound. The results were expressed in mg per 100 g of dry
weight.
2.3. Extract preparation of the wild Macrolepiota species
The extracts were prepared as previously described.12
2.4. Evaluation of the antioxidant activity of wild
Macrolepiota species
The methanolic extracts were re-dissolved in methanol at
20 mg mL−1. Successive dilutions from the stock solution
were made and subjected to in vitro assays.18 Four different
assays were performed: reducing power, DPPH radical-scaven-
ging activity, inhibition of β-carotene bleaching or β-carotene/
linoleate assay and thiobarbituric acid reactive substance
(TBARS) assay. The sample concentrations (mg mL−1) provid-
ing 50% of antioxidant activity or 0.5 of absorbance (EC50)
were calculated from the graphs of antioxidant activity per-
centages (DPPH, β-carotene/linoleate and TBARS assays) or
absorbance at 690 nm (ferricyanide/Prussian blue assay)
against sample concentrations. Trolox was used as a positive
control.
2.5. Evaluation of the antimicrobial activity of the wild
Macrolepiota species
The following bacteria strains were used for antimicrobial
testing: Bacillus cereus (clinical isolate), Enterobacter cloacae
(ATCC 35030), Staphylococcus aureus (ATCC 6538), methicillin-
resistant S. aureus (MRSA), Escherichia coli (ATCC 35210), anti-
biotic resistant E. coli (H2b), Pseudomonas aeruginosa (ATCC
27853) and antibiotic resistant P. aeruginosa (IBRS P001). The
following micromycetes were used: Aspergillus fumigatus (ATCC
9197), Aspergillus niger (ATCC6275), Aspergillus ochraceus (ATCC
12066), Aspergillus versicolor (ATCC 11730), Penicillium funiculo-
sum (ATCC 10509), Penicillium ochrochloron (ATCC 9112),
Penicillium verrucosum var. cyclopium (food isolate) and
Trichoderma viride (IAM 5061).
For the determination of the antimicrobial activity of
methanol extracts of Macrolepiota species, a modified microdi-
lution method was used.12,19–21 The results were presented as
minimum inhibitory concentrations (MIC), minimum bacteri-
cidal concentrations (MBC) and minimum fungicidal concen-
trations (MFC).
Food & Function Paper
This journal is © The Royal Society of Chemistry 2019 Food Funct., 2019, 10, 7678–7686 | 7679
Pu
bl
ish
ed
 o
n 
23
 O
ct
ob
er
 2
01
9.
 D
ow
nl
oa
de
d 
by
 In
sti
tu
to
 P
ol
ite
cn
ic
o 
de
 B
ra
ga
nc
a o
n 
6/
19
/2
02
0 
5:
17
:2
0 
PM
. 
View Article Online
2.6. Evaluation of antibiotic activity – synthesis inhibition of
pyocyanin in P. aeruginosa
The modified method for the synthesis inhibition of pyocyanin
was used as previously described by authors Sandy & Foong-
Yee22 and Glamočlija et al.12
2.7. Cytotoxicity and hepatotoxicity of wildMacrolepiota species
The cytotoxic properties were evaluated in human tumour cell
lines and in a non-tumour liver cell primary culture. The
extracts of three different Macrolepiota species were dissolved
in water/DMSO at 8 mg mL−1. The positive control was elipticine.
A hepatic cell line, designated as PLP2, was used to evaluate
the cytotoxicity.23 All results were expressed in GI50 values
(sample concentration that inhibited 50% of the net cell
growth; concentrations used in the assay were in the range of
6.25 µg mL−1–400 µg mL−1).
2.8. Statistical analysis
All analyses regarding chemical composition and biological
activities were performed in triplicate; each replicate was quan-
tified also three times. Data were expressed as mean and stan-
dard deviation. The statistical analysis was performed using
SPSS v. 23.0 (IBM Corp., Armonk, NY, USA), through one-way
ANOVA and the Tukey HSD test (α = 0.05); thus, if the presence
of less than three samples was recorded, the results were
treated by the Student t-test (p = 0.05).
3. Results and discussion
3.1. Macronutrients and hydrophilic compounds in wild
Macrolepiota species
Macronutrient composition and chemistry of hydrophilic com-
pounds (sugars, organic acids and phenolic acids) for the
studied wild Macrolepiota mushroom species are shown in
Table 1. Macrolepiota species are used in the diet after thermal
processing, mostly after cooking. A previous study has demon-
strated that cooked samples have lower nutrient concen-
trations and lower antioxidant activities.24
Carbohydrates were the most abundant constituents in all
of the tested mushrooms. Comparative investigation showed
that M. procera had the highest amount of carbohydrates
(60.3 ± 0.2 g per 100 g dw), followed by M. mastoidea
(51.58 ± 0.01 g per 100 g dw) and M. rhacodes (40.9 ± 0.2 g per
100 g dw). Proteins were present in larger amounts in
M. rachodes and M. mastoidea, while M. procera had the lowest
amount. The studied mushrooms were poor in ash and fat
contents, concurring with the literature3,8,10,25 that has
recently been reported. Energetic contributions of the samples
were in the range of 363.6–375.7 kcal per 100 g dw, (Table 1),
indicating that the studied species are good choices for low-
caloric diet. These results are in agreement with previous
studies pointing to high protein and carbohydrate contents
and low fat characteristics of the different Macrolepiota
species.24–26 Nutritional value of M. rhacodes has been studied
previously by Manjunathan et al.25 and the study revealed that
the species is a good source of carbohydrates and proteins,
with a low amount of fats which is in accordance with the
results obtained in this study. Our results are in agreement
with another previous report26 on nutritional analysis carried
out on three mushrooms namely, M. dolichaula, M. procera,
and M. rhacodes. These Macrolepiota mushrooms were rich in
nutrients, nutraceutical components and minerals and low in
fat,26 as well as Macrolepiota species presented in our current
work.
Free sugars found in the studied Macrolepiota species were
mannitol and trehalose. M. procera contained higher amounts
of mannitol and total sugars (12.5 ± 0.8 g per 100 g dw and
19 ± 1 g per 100 g dw, respectively) when compared to the
other two studied species (Table 1). The amounts of trehalose
and mannitol quantified for our samples are in agreement
with previously published results referring to M. procera.24,27
Other free sugars, melezitose and fructose, were found in the
samples M. procera from Portugal, while they were not detected
in our tested samples.24,27 Mannitol and trehalose are impor-
tant sugars with established biological functions. Regarding
mannitol, it has four Food and Drug Administration
(FDA)-approved uses: for the reduction of intracranial
pressure and brain mass, for the reduction of intraocular
pressure, for promoting diuresis for acute renal failure and
for promoting the excretion of toxic substances, materials,
and metabolites.28–31 It has been shown that trehalose can
protect mammalian tissues from desiccation as well as from
oxidative stress.32
Table 1 Macronutrients and hydrophilic compounds in the studied
Macrolepiota spp. (mean ± SD)a
Macrolepiota
mastoidea
Macrolepiota
rhacodes
Macrolepiota
procera
Nutritional value (g per 100 g dw)
Fat 3.62 ± 0.03a 3.8 ± 0.1a 1.9 ± 0.2b
Protein 32.36 ± 0.05b 41.42 ± 0.05a 29.2 ± 0.5c
Ash 12.44 ± 0.03b 13.9 ± 0.2a 8.5 ± 0.1c
Total carbohydrates 51.58 ± 0.01b 40.9 ± 0.2c 60.3 ± 0.2a
Energetic value
(kcal per 100 g dw)
368.37 ± 0.01b 363.6 ± 0.2c 375.7 ± 0.4a
Sugars (g per 100 g dw)
Mannitol 4.91 ± 0.08b 1.77 ± 0.01c 12.7 ± 0.4a
Trehalose 2.93 ± 0.06b 2.45 ± 0.01c 7.01 ± 0.04a
Total sugars 7.8 ± 0.2b 4.22 ± 0.02c 19.7 ± 0.4a
Organic acid (g per 100 g dw)
Oxalic acid 0.045 ± 0.005c 0.696 ± 0.001b 0.90 ± 0.01a
Malic acid 0.32 ± 0.01c 3.07 ± 0.04b 11.4 ± 0.1a
Citric acid nd nd 5.5 ± 0.7
Fumaric acid tr tr 0.49 ± 0.01
Total organic acids 0.37 ± 0.01c 3.77 ± 0.04b 18.3 ± 0.9a
Phenolic acid (mg per 100 g dw)
p-Hydroxybenzoic acid 0.109 ± 0.002c 0.251 ± 0.007b 1.045 ± 0.002a
p-Cumaric acid 0.040 ± 0.002b 0.016 ± 0.001c 0.225 ± 0.001a
Total phenolic
compounds
0.150 ± 0.001c 0.266 ± 0.006b 1.271 ± 0.002a
Cinnanic acid 0.036 ± 0.001c 0.058 ± 0.001b 0.952 ± 0.001a
a nd, not detected; dw, dry weight. In each column, different letters mean
significant differences between species (p < 0.05).
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The organic acids detected in higher amounts were malic
and oxalic acids. Fumaric acid was detected in lower amounts;
there were traces in species M. mastoidea and M. rhacodes,
while a higher value was recorded for M. procera. Citric acid
was found only in M. procera. M. procera contained the highest
amount of all organic acids, in comparison with M. mastoidea
and M. rhacodes (Table 1), with similar values to those reported
by Barros et al.15 for the same species. A previous study by
Tang et al.33 found that both citric acid and L-malic acid have
protective effects on myocardial ischemia/reperfusion injury
linking the activity of these organic acids to their anti-inflam-
matory, antiplatelet aggregation and direct cardiomyocyte pro-
tective effects.
M. procera was rich in phenolic acids when compared to
M. rhacodes and M. mastoidea, containing a much higher con-
centration of p-hydroxybenzoic and p-coumaric acids, as also
the related compound cinnamic acid (Table 1). Jose &
Radhamany34 qualitatively detected phenolic acids in the
methanolic extract of M. mastoidea, such as p-hydroxybenzoic
acid, vanillic acid, gentisic acid, coumarin and p-coumaric
acid. The differences in composition regarding phenolic com-
pounds described by Jose and Radhamany34 and the results
presented in this study could be attributed to different extrac-
tion techniques used. On the other hand, Nowacka et al.35
identified only protocatechuic acid in the ethanolic extracts of
M. procera from Poland. Nonetheless, the ethanolic extract of
M. procera from Portugal revealed only the presence of cin-
namic acid.36 Our results indicate a slightly different compo-
sition in comparison with the studies by Nowacka et al.35 and
Taofiq et al.,36 which is attributed to different solvents used
for the extraction (ethanol and methanol). Phenolic acids are
well known for their antioxidant properties,37 but they also
revealed antimicrobial activity24,38,39 with the potential against
microbial multi-resistances.40
3.2. Lypophilic compounds in wild Macrolepiota species
The results of the lipophilic compounds obtained for three
Macrolepiota species are shown in Table 2.
Regarding the fatty acid composition of the studied species,
linoleic acid was found in higher amounts (C18:2n6, PUFA),
followed by palmitic (C16:0, SFA) and oleic (C18:1n9, MUFA)
acids. All tested mushrooms were rich in polyunsaturated fatty
acids (PUFA), while saturated (SFA) and monounsaturated
(MUFA) fatty acids were detected in lower amounts. PUFA have
their important role in the prevention of cardiovascular
disease, diabetes, depression, Alzheimer’s disease, cancer, and
dementia, although there are some controversies about their
effects.41 Comparing between species, M. rhacodes had the sig-
nificant highest content of PUFA; M. procera possessed the sig-
nificantly largest amount of SFA, while M. mastoidea gave the
highest percentage of MUFA (Table 2). In a previous study by
Fernandes et al.,42 the fatty acids of M. procera included 24
compounds, linoleic, palmitic and oleic acids being the major
compounds. Despite some differences regarding individual
fatty acids, the general percentages obtained for SFA, MUFA
and PUFA are similar to those presented in other studies.24,27,43
For the studied mushrooms, three tocopherol isoforms
were detected, with M. mastoidea and M. rachodes being the
ones with higher total tocopherol content, respectively.
Although Fernandes et al.27 found that β-tocopherol predomi-
nated in the dried samples of M. procera, β-tocopherol was the
most abundant isoform found in M. mastoidea and
M. rhacodes tested in this study, while δ-tocopherol was only
detected in M. procera. α-Tocopherol was found in lower
amounts in all of the tested Macrolepiota species (Table 2). It
was previously established that tocopherols are good antioxi-
dants indicating that α-tocopherol mainly inhibits the pro-
duction of new free radicals, while γ-tocopherol traps and neu-
tralizes the existing free radicals.44
3.3. Antioxidant activities of wild Macrolepiota species
The results of the antioxidant activities of the tested methano-
lic extracts of Macrolepiota species, carried out by four
different assays measuring free radical scavenging activity,
reducing power and lipid peroxidation inhibition, are pre-
Table 2 Lipophilic compounds in the studied Macrolepiota spp.
(mean ± SD)a
Macrolepiota
mastoidea
Macrolepiota
rhacodes
Macrolepiota
procera
C6:0 0.044 ± 0.004 0.027 ± 0.002 0.46 ± 0.08
C8:0 0.027 ± 0.002 0.027 ± 0.001 0.09 ± 0.02
C10:0 0.028 ± 0.001 0.035 ± 0.002 0.03 ± 0.01
C12:0 0.074 ± 0.001 0.084 ± 0.004 0.07 ± 0.02
C14:0 0.29 ± 0.01 0.369 ± 0.004 0.04 ± 0.07
C14:1 0.008 ± 0.001 nd 0.030 ± 0.001
C15:0 0.28 ± 0.01 0.53 ± 0.01 0.41 ± 0.05
C16:0 15.84 ± 0.05 10.00 ± 0.07 21 ± 1
C16:1 1.55 ± 0.01 0.71 ± 0.01 1.4 ± 0.1
C17:0 0.150 ± 0.002 0.157 ± 0.009 0.19 ± 0.01
C18:0 0.88 ± 0.01 1.16 ± 0.01 1.96 ± 0.05
C18:1n9 11.10 ± 0.01 6.06 ± 0.07 8.3 ± 0.2
C18:2n6 66.59 ± 0.03 78.62 ± 0.07 64 ± 1
C18:3n3 0.120 ± 0.001 0.081 ± 0.005 0.17 ± 0.01
C20:0 0.170 ± 0.001 0.112 ± 0.008 0.09 ± 0.01
C20:1 0.080 ± 0.004 0.025 ± 0.001 0.07 ± 0.01
C20:2 0.094 ± 0.001 0.12 ± 0.01 0.08 ± 0.01
C20:3n3 + C21:0 0.80 ± 0.04 0.32 ± 0.01 0.26 ± 0.02
C20:5n3 0.32 ± 0.01 0.095 ± 0.006 0.54 ± 0.05
C22:0 0.67 ± 0.01 0.75 ± 0.04 0.18 ± 0.02
C23:0 0.055 ± 0.001 0.062 ± 0.001 0.05 ± 0.01
C24:0 0.65 ± 0.01 0.66 ± 0.01 0.58 ± 0.08
C24:1 0.17 ± 0.01 nd 0.09 ± 0.01
Total SFA
(% of total FA)
19.16 ± 0.06b 13.97 ± 0.03c 25 ± 1a
Total MUFA
(% of total FA)
12.91 ± 0.01a 6.79 ± 0.07c 9.92 ± 0.09b
Total PUFA
(% of total FA)
67.92 ± 0.06b 79.2 ± 0.1a 65 ± 1c
Tocopherols (µg per 100 g dw)
α-Tocopherol 0.42 ± 0.03b 0.21 ± 0.01c 1.1 ± 0.1a
β-Tocopherol 82 ± 2b 61 ± 1b nd
δ-Tocopherol Nd nd 26.1 ± 2
Total tocopherols 82 ± 2a 61 ± 1b 27 ± 2c
a nd, not detected; dw, dry weight. bMeans statistical differences
between two samples obtained by the Student t-test. In each line,
different letters mean significant differences between species (p <
0.05).
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sented in Table 3. All studied mushroom extracts possessed
antioxidant potential, but M. procera was more potent in most
of the cases. The highest total phenolic content was shown for
the methanolic extract of M. rhacodes (39.5 ± 0.7 mg GAE per g
extract). M. rhacodes and M. procera exhibited the same redu-
cing power when evaluated through the ferricyanide/Prussian
blue assay (EC50 = 1.62 ± 0.01 and 1.61 ± 0.01 mg mL
−1,
respectively) and possessed similar results for DPPH radical
scavenging activity (EC50 = 3.4 ± 0.2 and 3.7 ± 0.2 mg mL
−1,
respectively). The methanolic extract of M. procera exhibited
the highest lipid peroxidation inhibition, since it presented
the lowest EC50 values for β-carotene/linoleate and TBARS
assays (Table 3). M. mastoidea showed the lowest antioxidant
activity in comparison with the other two studied mushrooms.
M. procera (EC50 3.7 mg mL
−1;27 EC50 17.76 mg dry extract
per mg DPPH;35 EC50 0.331 mg mL
−1 (ref. 45)) and
M. mastoidea (EC50 3.7 mg mL
−1)34 have been previously
studied and have demonstrated a good DPPH radical scaven-
ging activity, which is comparable with our results for
M. procera (EC50 3.7 mg mL
−1) and M. mastoidea (EC50 5.4 mg
mL−1). Barros et al.24 have shown the antioxidant potential of
M. mastoidea and M. procera dried mushroom samples
extracted with methanol: DPPH scavenging activity (EC50
8.18 mg mL−1 and 5.38 mg mL−1, respectively), reducing
power (EC50 4.35 mg mL
−1 and 4.18 mg mL−1, respectively),
β-carotene/linoleate (EC50 6.48 mg mL−1 and 5.19 mg mL−1,
respectively), TBARS assay (EC50 24.20 mg mL
−1 and >50 mg
mL−1, respectively). These results are comparable with the
ones obtained in our study (Table 3). The ethanolic extract of
M. procera was studied for its anti-DPP. The observed anti-
oxidant activity is mostly a function of the bioactive constitu-
ents of the mushroom species, such as phenolic compounds,
tocopherols and organic acids, as generalized for other mush-
room species.10
3.4. Antimicrobial activities of wild Macrolepiota species
Methanolic extracts of M. mastoidea, M. rhacodes and
M. procera showed antimicrobial activity against all tested
strains, but at different levels (Table 4). MIC obtained in micro-
dilution assay (section 2.5) was between 0.20 and 4.00 mg
Table 3 Antioxidant activity in the studied Macrolepiota spp
Macrolepiota
mastoidea
Macrolepiota
rhacodes
Macrolepiota
procera
Reducing power Folin–Ciocalteu (mg GAE per g extract) 17.35 ± 0.05b 39.5 ± 0.8a 13.9 ± 0.6c
Ferricyanide/Prussian blue (EC50; mg mL
−1) 2.10 ± 0.01a 1.62 ± 0.01b 1.61 ± 0.01b
Radical scavenging activity DPPH scavenging activity (EC50; mg mL
−1) 5.4 ± 0.2a 3.4 ± 0.2b 3.7 ± 0.2b
β-Carotene/linoleate (EC50; mg mL−1) 1.85 ± 0.09a 1.08 ± 0.08b 0.48 ± 0.04c
Lipid peroxidation inhibition TBARS (EC50; mg mL
−1) 0.47 ± 0.02a 0.41 ± 0.03a 0.27 ± 0.02b
Concerning the Folin–Ciocalteu assay, higher values mean higher reducing power; for the other assays, the results are presented in EC50 values,
what means that higher values correspond to lower reducing power or antioxidant potential. EC50: Extract concentration corresponding to 50% of
antioxidant activity or 0.5 of absorbance for the ferricyanide/Prussian blue assay.
Table 4 Antimicrobial activity of the methanolic extracts of the studied Macrolepiota spp. in mg mL−1
Bacteria
Macrolepiota mastoidea Macrolepiota rhacodes Macrolepiota procera Streptomycine Ampicillin
MIC/MBC MIC/MBC MIC/MBC MIC/MBC MIC/MBC
Bacillus cereus 0.20/0.25 0.35/0.50 1.50/2.00 0.0015/0.0030 0.006/0.025
Staphylococcus aureus 0.75/1.00 0.75/1.00 0.75/1.00 0.006/0.012 0.012/0.025
MRSA 2.00/4.00 2.00/4.00 2.00/4.00 0.100/— —/—
Escherichia coli 1.00/2.00 2.00/4.00 1.50/2.00 0.050/0.100 0.100/0.200
Rez. E. coli 0.75/1.00 2.00/4.00 3.00/4.00 0.100/0.200 0.200/—
Pseudomonas aeruginosa 2.00/4.00 2.00/4.00 2.00/4.00 0.025/0.050 0.050/0.100
Rez. P. aeruginosa 1.00/2.00 2.00/4.00 2.00/4.00 0.050/0.100 0.200/—
Enterobacter cloacae 1.00/2.00 1.00/2.00 3.00/4.00 0.003/0.006 0.006/0.012
Fungi
Macrolepiota mastoidea Macrolepiota rhacodes Macrolepiota procera Bifonazole Ketoconazole
MIC/MFC MIC/MFC MIC/MFC MIC/MFC MIC/MFC
Aspergillus fumigatus 1.00/2.00 4.00/8.00 2.00/4.00 0.150/0.200 0.200/0.500
Aspergillus versicolor 2.00/4.00 1.00/2.00 1.00/2.00 0.100/0.200 0.200/0.500
Aspergillus ochraceus 0.50/1.00 1.00/2.00 0.50/1.00 0.150/0.200 0.150/0.200
Aspergillus niger 1.00/2.00 1.00/2.00 1.50/2.00 0.150/0.200 0.200/0.500
Trichoderma viride 0.25/0.50 0.50/1.00 0.50/1.00 0.150/0.200 1.000/1.500
Penicillium funiculosum 1.00/2.00 0.75/1.00 1.00/2.00 0.200/0.250 0.200/0.500
Penicillium ochrochloron 1.00/2.00 1.00/2.00 1.00/2.00 0.200/0.250 1.000/1.500
Penicillium verrucosum var. cyclopium 2.00/4.00 2.00/6.00 2.00/4.00 0.100/0.200 0.200/0.300
— no activity; Rez – resistant.
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mL−1, while MBC was 0.25–4.00 mg mL−1 and MFC was
0.50–8.00 mg mL−1 (Table 4). The most sensitive species tested
were B. cereus and T. viride for all tested extracts, while the
most resistant strains were resistant S. aureus (MRSA),
P. aeruginosa (IBRS P001), A. fumigatus and P. verrucosum var.
cyclopium. The best antibacterial activity was obtained for the
M. mastoidea methanolic extract, while the lowest activity was
recorded for the methanolic extract of M. procera, against all
the tested bacteria. The best antifungal effects were achieved
with M. mastoidea and M. procera extracts, while M. rhacodes
showed the lowest values. The tested methanol extracts exhibi-
ted a similar or lower activity compared to commercial anti-
biotics and fungicides, while against some resistant bacteria
(S. aureus, E. coli and P. aeruginosa) all extracts possessed
higher activity when compared to ampicillin (Table 4).
The methanol extracts of M. procera from Turkey were
found to be able to inhibit the growth of Gram (+) and Gram
(−) bacteria, as well as yeasts in the disc diffusion method.39
The antimicrobial potential of the same extract from speci-
mens collected in Serbia possessed slightly weaker activity. It
inhibited three species of bacteria and seven tested fungi.45
The ethanolic extracts of M. procera from Poland revealed mod-
erate antimicrobial activity against several tested bacteria.35 On
the other hand, the previous study46 indicated that M. procera
did not possess activity against methicillin resistant strain
Staphylococcus aureus (MRSA),46 while we obtained activity
against MRSA. In the current study, all the methanolic extracts
of Macrolepiota species inhibited resistant bacteria S. aureus,
E. coli and P. aeruginosa (Table 4). Our study is in agreement
with the results previously reported by Alves et al.47 Mushroom
extracts could be an alternative to synthetic antimicrobials
against pathogenic micro-organisms resistant to conventional
treatments. The results on the activity of mushroom extracts
against resistant bacteria investigated herein are of extreme
importance since antimicrobial resistance has become an
emerging medical problem during the recent decades. Among
others, World Health Organization includes infectious dis-
eases caused by pathogenic microorganisms as one of the top
five major global causes of fatal outcome.48
Pyocyanin is a redox-active toxin produced by P. aeruginosa.
These pigments are involved in quorum sensing, virulence, and
iron acquisition.49 Recently, a study found that the inhibited
biosynthesis of pyocyanin leads to a decrease in P. aeruginosa
pathogenicity in vitro. This suggests that pyocyanin is most
responsible for the initial colonization of P. aeruginosa in vivo.50
Our results on pyocyanin inhibition demonstrated that the
extract of M. mastoidea had an influence on the reducing pro-
duction of pyocyanin similar to antibiotics (Fig. 1).
3.5. Cytotoxicity of wild Macrolepiota species
The effect of methanolic extracts on the growth of four human
tumor cell lines (MCF-7, NCI-H460, HeLa and HepG2) was
determined, and the values of GI50 are detailed in Table 5. The
extract of M. mastoidea revealed activity against HepG2 with
GI50 = 181 µg mL
−1, being less effective against MCF-7 and
HeLa, and the least effective against NCI-H460.
The tested extracts of M. rhacodes and M. procera did not
show an effect against the tested cell lines at the maximum
dose 400 µg mL−1. Only the extract of M. rhacodes possessed
activity against the tumor cell line MCF-7. The methanolic
extracts of Macrolepiota species did not have cytotoxic effects
towards non-tumor liver primary cells at the tested concen-
trations (PLP2; GI50 > 400 µg mL
−1; Table 5). It seems that
M. mastoidea has the greatest potential to inhibit the prolifer-
ation of the hepatocellular carcinoma cell line. The results on
M. mastoidea activity against the HepG2 cell line are of particu-
lar importance, since hepatocellular carcinoma is the most
common primary liver malignancy and is a leading cause of
cancer-related death worldwide.51 The results are gaining more
Fig. 1 Reduction of P. aeruginosa pyocyanin production by the metha-
nolic extracts of Macrolepiota species, tested at sub-MICs (mg mL−1).
Table 5 Antitumor activity and hepatotoxicity of the methanolic extracts of the studied Macrolepiota spp. (mean ± SD)
Macrolepiota
mastoidea
Macrolepiota
rhacodes
Macrolepiota
procera Elipticine
Toxicity for human tumor cell lines
MCF-7 (breast carcinoma) (GI50, µg mL
−1) 237 ± 14a 305.49 ± 19a >400 0.91 ± 0.04
NCI-H460 (non-small cell lung cancer) (GI50, µg mL
−1) 287 ± 10 >400 >400 1.03 ± 0.09
HeLa (cervical carcinoma) (GI50, µg mL
−1) 250 ± 9 >400 >400 1.91 ± 0.06
HepG2 (hepatocellular carcinoma) (GI50, µg mL
−1) 181 ± 16 >400 >400 1.1 ± 0.2
Hepatotoxicity
PLP2 (GI50, µg mL
−1) >400 >400 >400 3.2 ± 0.7
aMeans statistical differences between two samples obtained by the Student t-test.
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importance, since none of the tested extracts exhibited hepato-
toxicity on liver primary cells, indicating that the extracts are
non-toxic to healthy cells and that they selectively act on
tumour cell lines.
In the literature, there are several studies about the anti-
cancer and cytotoxic activity for M. procera.45 The study by
Kosanić et al.45 showed that the methanolic extract of
M. procera exhibited the cytotoxic activity on human epithelial
carcinoma HeLa cell lines, human lung carcinoma A549 cell
lines, and human colon carcinoma LS174 cell lines. The
M. procera methanolic extract showed cytotoxic activity with
IC50 values ranging from 25.55 to 68.49 µg mL
−1.45 Moreover,
Arora et al.52 demonstrated that the ethanolic extract of
M. procera revealed the cytotoxic properties upon COLO-205
cancer cells.
Nowadays, medicinal mushrooms are used in many
different ways as dietary foods, dietary supplement products, a
new class of drugs (mushroom pharmaceuticals), natural bio-
control agents, cosmeceuticals and others.53 Thus, the studied
mushroom species could meet most of the above properties.
4. Conclusions
It was shown that the species are rich sources of proteins with
a low caloric value. Mannitol and trehalose were the most
abundant free sugars in the investigated species. Regarding
phenolic compounds, p-hydroxybenzoic and p-coumaric acids
were detected, while malic and citric acids were representatives
of organic acids found in the specimens. PUFA were the most
dominant fatty acids in all of the investigated samples.
Tocopherols were detected in the mushrooms, with
α-tocopherol present in all of the species but with the lowest
concentration. The tested mushrooms were revealed to be bio-
active, against possessing antimicrobial activity against resist-
ant bacteria and therefore can be useful as potential natural
antimicrobial agents. All of the tested mushroom species pos-
sessed notable antioxidant potential, tested by different
assays. As for the antimicrobial activity, the most important
findings are related to the antibacterial potential of
Macrolepiota extracts against resistant strains of Escherichia,
Pseudomonas and Staphylococcus. Regarding the studies on
cytotoxicity, the most promising effect was noted for
M. mastoidea on hepatocellular carcinoma cell lines. These
wild growing mushrooms might be used directly in the diet to
promote health, since it was demonstrated that the investi-
gated edible Macrolepiota species are indeed functional foods.
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